Multiple innovative drug ETFs rise over 5%.

Medical services and the concept of CRO continue to strengthen, with more than ten related stocks hitting the limit up. Several ETFs, including the Innovation Drug ETF by Guotai, the Innovation Drug ETF by Huitianfu, and the Innovation Drug ETF by Yifangda, have risen over 5%.